TRANSCEND CAPITAL ADVISORS, LLC – Eli Lilly and Company Transaction History
TRANSCEND CAPITAL ADVISORS, LLC portfolio value:
$4.35M
portfolio value
TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.61% | -83 shares | -38K | $323.35 | 13.46K |
| Q2 2022 | share | Decrease | -0.38% | -51 shares | 498K | $324.23 | 13.54K |
| Q1 2022 | share | Decrease | -0.45% | -62 shares | 121K | $286.37 | 13.59K |
| Q4 2021 | share | Increase | +2.38% | 318 shares | 458K | $277.25 | 13.65K |
| Q3 2021 | share | Increase | +9.49% | 1.15K shares | 515K | $230.3 | 13.33K |
| Q2 2021 | share | Increase | +74.27% | 5.19K shares | 1.49M | $228.04 | 12.18K |
| Q1 2021 | share | Decrease | -3.32% | -240 shares | 81K | $184.81 | 6.99K |
| Q4 2020 | share | Increase | 0.00% | 7.23K shares | 1.22M | $166.32 | 7.23K |